Robert W. Baird Issues Pessimistic Forecast for DENTSPLY SIRONA (NASDAQ:XRAY) Stock Price

DENTSPLY SIRONA (NASDAQ:XRAY) had its target price lowered by investment analysts at Robert W. Baird from $31.00 to $24.00 in a research note issued to investors on Friday,Benzinga reports. The brokerage presently has a “neutral” rating on the medical instruments supplier’s stock. Robert W. Baird’s target price would suggest a potential upside of 39.05% from the company’s current price.

A number of other research analysts have also commented on XRAY. Leerink Partners lowered shares of DENTSPLY SIRONA from an “outperform” rating to a “market perform” rating in a research report on Thursday. Needham & Company LLC decreased their target price on DENTSPLY SIRONA from $34.00 to $29.00 and set a “buy” rating on the stock in a research note on Friday, October 25th. Evercore ISI lowered their price target on DENTSPLY SIRONA from $29.00 to $27.00 and set an “outperform” rating on the stock in a report on Tuesday, October 8th. Barrington Research reissued an “outperform” rating and set a $36.00 price objective on shares of DENTSPLY SIRONA in a report on Friday, September 20th. Finally, StockNews.com raised shares of DENTSPLY SIRONA from a “hold” rating to a “buy” rating in a research note on Wednesday. Five research analysts have rated the stock with a hold rating and six have given a buy rating to the company. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $31.00.

DENTSPLY SIRONA Trading Down 28.0 %

Shares of DENTSPLY SIRONA stock opened at $17.26 on Friday. The company’s 50-day moving average price is $24.82 and its 200-day moving average price is $25.98. The company has a current ratio of 1.33, a quick ratio of 0.87 and a debt-to-equity ratio of 0.57. DENTSPLY SIRONA has a 12-month low of $17.22 and a 12-month high of $37.60. The company has a market cap of $3.50 billion, a price-to-earnings ratio of -20.07, a PEG ratio of 1.31 and a beta of 1.02.

Hedge Funds Weigh In On DENTSPLY SIRONA

Institutional investors and hedge funds have recently made changes to their positions in the business. Mitsubishi UFJ Asset Management Co. Ltd. increased its stake in DENTSPLY SIRONA by 44.2% in the 1st quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 141,117 shares of the medical instruments supplier’s stock worth $4,684,000 after purchasing an additional 43,230 shares during the period. Scientech Research LLC bought a new stake in DENTSPLY SIRONA during the 2nd quarter valued at $846,000. Seven Eight Capital LP purchased a new stake in DENTSPLY SIRONA during the 1st quarter valued at $1,409,000. Illinois Municipal Retirement Fund increased its position in shares of DENTSPLY SIRONA by 369.9% in the first quarter. Illinois Municipal Retirement Fund now owns 123,580 shares of the medical instruments supplier’s stock valued at $4,102,000 after acquiring an additional 97,281 shares during the period. Finally, Intech Investment Management LLC bought a new position in shares of DENTSPLY SIRONA during the first quarter valued at about $1,202,000. Institutional investors own 95.70% of the company’s stock.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.